Table 1. Treatment strategy for optimization of in vitro DN model.
Treatment Group | AGE (150μg/ml) | Ang II (1μM) | HG (30 mM) | Mannitol(30 mM) |
---|---|---|---|---|
1 | - | - | - | - |
2 | - | - | - | + |
3 | - | - | + | - |
4 | - | + | + | - |
5 | + | - | + | - |
6 | + | + | + | - |
Treatment Group | AGE (150μg/ml) | Ang II (1μM) | HG (30 mM) | Mannitol(30 mM) |
---|---|---|---|---|
1 | - | - | - | - |
2 | - | - | - | + |
3 | - | - | + | - |
4 | - | + | + | - |
5 | + | - | + | - |
6 | + | + | + | - |